Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

Prostate cancer that has become resistant to hormone ... important for future research to discover which patients will respond best. NXP800 has been granted Fast-Track and Orphan Drug Designation by ...

Scientists from The Institute of Cancer Research, London, showed that the drug, NXP800, discovered at the same institute, slowed the growth of prostate cancer cells, including in cancer cells that are ...